CryoLife Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
140,763.00
144,641.00
145,898.00
180,380.00
189,702.00
262,841
Cost of Goods Sold (COGS) incl. D&A
52,383.00
55,377.00
57,314.00
65,907.00
66,145.00
100,649
Gross Income
88,380.00
89,264.00
88,584.00
114,473.00
123,557.00
162,192
SG&A Expense
73,620.00
80,426.00
74,430.00
92,668.00
104,687.00
144,480
EBIT
14,760.00
8,838.00
14,154.00
-
18,870.00
17,712
Unusual Expense
4,141.00
116.00
8,800.00
7,900.00
10,900.00
8,400
Non Operating Income/Expense
12,740.00
69.00
469.00
7,478.00
260.00
141
Interest Expense
71.00
-
-
3,043.00
4,881.00
15,788
Pretax Income
23,292.00
8,703.00
5,868.00
18,412.00
3,561.00
6,391
Income Tax
7,120.00
1,381.00
1,863.00
7,634.00
143.00
3,551
Consolidated Net Income
15,805.00
7,161.00
3,918.00
10,570.00
3,641.00
2,813
Net Income
15,805.00
7,161.00
3,918.00
10,570.00
3,641.00
2,813
Net Income After Extraordinaries
15,805.00
7,161.00
3,918.00
10,570.00
3,641.00
2,813
Net Income Available to Common
15,805.00
7,161.00
3,918.00
10,570.00
3,641.00
2,813
EPS (Basic)
0.57
0.25
0.14
0.32
0.11
0.08
Basic Shares Outstanding
26,885.00
27,379.00
27,744.00
31,855.00
33,008.00
36,412
EPS (Diluted)
0.57
0.25
0.14
0.32
0.11
0.08
Diluted Shares Outstanding
27,698.00
28,313.00
28,542.00
32,822.00
34,163.00
36,412
EBITDA
20,603.00
14,866.00
20,017.00
30,189.00
28,603.00
35,807
Non-Operating Interest Income
4.00
50.00
45.00
72.00
212.00
226
Other After Tax Income (Expense)
367.00
161.00
87.00
208.00
63.00
27

About CryoLife

View Profile
Address
1655 Roberts Boulevard NW
Kennesaw Georgia 30144
United States
Employees -
Website http://www.cryolife.com
Updated 07/08/2019
CryoLife, Inc. is a medical devices company, which engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. It operates through the Medical Devices and Preservation Services segments. The Medical Devices segment includes BioGlue; BioFoam; On-X products; CardioGenesis cardiac laser therapy; PerClot; PhotoFix, Hemodialysis Reliable Outflow Graft; and ProCol Vascular Bioprosthesis.